Tissue Collection From Cancer and Blood Disorder Patients
Part of Blood & lymphatic, Cancer clinical trials.
This study collects tissue samples from patients with cancer or blood disorders, and from their matching family members who might donate stem cells for transplant. The samples help researchers understand these diseases and develop better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with cancer (solid tumor) or a blood disorder (either cancerous or non-cancerous)
- You are at least 2 years old
- You are being screened at the NIH, already in an NIH study, a matching family member of an NIH patient, or referred by your home health provider
- You or your legal guardian can understand the study and agree to participate
- You are willing to have tissue samples collected
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial helps the NIH collect and track your tissue or fluid samples used in cancer and tumor research. It may help researchers learn from your samples and medical information, but it is mainly about sample collection and data tracking.
This study collects tissue or other cancer-related samples to help researchers better understand cancer and develop better tests or treatments. You can join if you are being evaluated for or treated for cancer, and you agree to let your samples be used for research.
This study collects blood and tissue samples from people with cancer or suspected cancer, or from their blood relatives. Researchers use these samples to better understand cancer and develop new treatments.
This trial studies how different blood cancers and early (pre-cancer) blood conditions work, using tumor/blood tissue samples. It may help researchers learn more about disease biology for future treatments, with little to no extra risk if samples come from routine care.
This study collects and stores blood/tissue samples (called biospecimens) to support immunotherapy research at the cancer center. If you may qualify, your samples help researchers test new immune-based cancer treatments.
This study is a general screening step at the NIH Clinical Center to check whether you might qualify for other NHLBI research protocols. It helps match you (or a donor/healthy volunteer) to the right study and confirms you can consent to participate.
Hear when a new Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.